Ovarian cancer: open trials in Thailand

• NCT07851025

  Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer

  Trial Treatment · Phase 3 · AstraZeneca

  Bangkok

  Registry updated 2026-11-06

• NCT07816666

  Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer

  Trial Treatment · Phase 3 · AstraZeneca

  Bangkok · Hat Yai · Muang

  Registry updated 2026-10-16

• NCT05123482

  A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  Trial Treatment · Phase 1/2 · AstraZeneca

  Bangkok · Chiang Mai

  Registry updated 2026-10-13

• NCT06824467

  A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Ramathibodi Hospital. (Site 3402), Bangkok · Faculty of Medicine Siriraj Hospital (Site 3401), Bangkok

  Registry updated 2026-10-13

• NCT07318558

  A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Ramathibodi Hospital. (Site 3402), Bangkok · Faculty of Medicine Siriraj Hospital (Site 3401), Bangkoknoi · Faculty of Medicine - Khon Kaen University (Site 3403), Muang

  Registry updated 2026-10-13

• NCT07218809

  AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

  Trial Treatment · Phase 3 · AstraZeneca

  Bangkok · Chiang Mai · Dusit · Khon Kaen · Songkhla

  Registry updated 2026-07-21

All Ovarian cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error